Joost Leeflang Appointed New COCIR President

COCIRAt the COCIR General Assembly in Brussels, COCIR President Kevin Haydon announced that he would stand down from COCIR Presidency at the end of April 2015. Joost Leeflang has been elected as the new COCIR President and will represent Philips on the COCIR Board. Mr Leeflang has been with Philips for 20 years, holding positions in the Netherlands, Ukraine, Russia and as CEO in Central and Eastern Europe and was very recently appointed as Senior Vice President & Business Leader for Diagnostic Imaging.

Outgoing COCIR President Kevin Haydon thanked the COCIR membership and team for their excellent cooperation and work, saying "COCIR has successfully built a leading and united industry voice and is now recognised as an important industry stakeholder, sharing its competencies to build more sustainable healthcare system with access for safe, affordable healthcare for all European citizens."

On being appointed as new COCIR President at the COCIR General Assembly, Joost Leeflang said "I am happy to continue to capitalize on what COCIR has achieved. All COCIR industries have been working smartly together delivering highly innovative products and services. We are proud to have key global players based in Europe with important research and innovation investments that should be considered in EU policy making. Our industries have changed their business models providing integrated care approaches. They have successfully developed solutions critical to the transformation of our healthcare systems, to ensure these remain sustainable for generations to come."

COCIR Secretary General Nicole Denjoy expressed her thanks to Kevin Haydon for his strategic drive towards more recognition of our key healthcare technologies, saying "Kevin Haydon used his business insights to steer COCIR and to help build our presence in Europe and beyond. We wish him a wellearned retirement. I am looking forward to working with Joost Leeflang whose international business expertise will continue strengthening and guiding COCIR in the coming years."

About COCIR
COCIR is the European Trade Association representing the medical imaging, health ICT and electromedical industries. Founded in 1959, COCIR is a non-profit association headquartered in Brussels (Belgium) with a China Desk based in Beijing since 2007. COCIR is unique as it brings together the healthcare, IT and telecommunications industries.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...